1957
DOI: 10.4269/ajtmh.1957.6.1066
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Strongyloides Stercoralis Infection with Intravenous Gentian Violet

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1958
1958
2015
2015

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In the absence of such perfect sanitary conditions, reliance on anti-helminthic drugs is a reasonable option. The treatment of Strongyloides has come a long way since the days when intravenous gentian violet was introduced in 1950 [39] . Currently, three drugs have been approved for the treatment of Strongyloides: Albendazole, Mebendazole and Ivermectin.…”
Section: Treatmentmentioning
confidence: 99%
“…In the absence of such perfect sanitary conditions, reliance on anti-helminthic drugs is a reasonable option. The treatment of Strongyloides has come a long way since the days when intravenous gentian violet was introduced in 1950 [39] . Currently, three drugs have been approved for the treatment of Strongyloides: Albendazole, Mebendazole and Ivermectin.…”
Section: Treatmentmentioning
confidence: 99%
“…A recent study found that GV was effective against the protozoa Leishmania , the causative agent of cutaneous leshmaniasis, both in vitro and in vivo in a mouse model . Gentian violet has also been used historically to treat the parasitic nematodes Strongyloides and Enterobium (pinworm) .…”
Section: Additional Antimicrobial Effectsmentioning
confidence: 99%